Illumina, Inc. ILMN
Illumina (ILMN) is a global leader in life sciences technology, specializing in genetic sequencing and array-based solutions. The company develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its primary offerings include sequencing instruments, consumables such as flow cells and reagents, and related services that support genomic research, clinical diagnostics, and applied markets. Illumina serves a diverse customer base including academic institutions, government laboratories, hospitals, and biotechnology companies worldwide, enabling advancements in areas like oncology, reproductive health, and agrigenomics. The company operates through a direct sales force and a network of distributors, generating revenue primarily from the sale of its proprietary sequencing platforms and the recurring sale of consumables used to run those systems. Its business model is built on a razor-and-blades approach, where instrument placements drive ongoing high-margin consumable sales and service contracts.
LSTM Forecast
Forecast model is not trained yet for this market.
Train and backfill the LSTM forecast to surface a directional view here.